Loading institutional data...
Loading institutional data...
Held by 868 of 5,944 reporting institutions (98th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 190 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WELL | $165.2B | 170.7× | — | 15.3× | 35.6% | 40.1% | 8.6% | 2.2% | 1.5% | — | 1,425 |
| EQIX | $103.7B | 76.8× | 26.2× | 11.3× | 5.4% | 51.1% | 14.6% | 9.5% | 9.5% | — | 1,229 |
| AMT | $78.4B | 31.1× | 12.9× | 7.4× | 5.1% | — | 24.7% | 72.0% | 72.0% | — | 1,662 |
| O | $58.6B | 53.6× | — | 10.2× | 9.1% | — | 18.4% | 2.7% | 2.7% | — | 1,389 |
| XHG | $47.8B | — | — | 932.4× | -82.2% | 2.2% | -205% | 11.9% | 12.4% | — | 1 |
| PLDGP | $47.6B | 14.4× | — | 5.4× | 7.2% | — | 37.9% | 6.3% | 3.8% | — | 9 |
| CBRE | $44.7B | 39.3× | — | 1.1× | 13.4% | 18.7% | 2.9% | 13.0% | 7.1% | — | 1,020 |
| VTR | $43.9B | 171.3× | — | 7.5× | 18.5% | — | 4.5% | 2.1% | 1.0% | — | 891 |
| IRM | $37.6B | 259.4× | 24.5× | 5.5× | 12.2% | — | 2.2% | -15.5% | 1.0% | 7.4× | 1,043 |
| EXR | $31.7B | 32.7× | 14.8× | 9.4× | 3.7% | 72.8% | 28.8% | 7.3% | 7.3% | — | 722 |
| VICI | $28.2B | 10.1× | — | 7.0× | 4.1% | 99.3% | 69.3% | 10.0% | 6.2% | — | 898 |
| AVB | $26.6B | 25.6× | 12.2× | 8.7× | 4.4% | — | 34.7% | 9.1% | 5.0% | 3.2× | 715 |
| EQR | $25.6B | 23.0× | — | — | — | — | — | 10.1% | 5.8% | — | 681 |
| SBAC | $18.9B | 18.2× | 20.0× | 6.7× | 5.1% | 75.5% | 37.4% | -21.7% | 17.2% | 7.4× | 636 |
| BEKE | $18.7B | 140.8× | 40.7× | 1.4× | -85.5% | 21.4% | 3.2% | 4.5% | 4.4% | 0.4× | 197 |
| INVH | $18.6B | 31.8× | — | 6.8× | 4.2% | — | 21.5% | 6.2% | 3.3% | — | 560 |
| WY | $18.6B | 57.4× | 18.7× | 2.7× | -3.1% | 14.8% | 4.7% | 3.4% | 2.2% | 4.1× | 868 |
| ESS | $18.6B | 27.7× | 12.3× | 9.8× | 6.4% | 69.9% | 37.2% | 12.7% | 12.7% | — | 582 |
| JLL | $17.5B | 22.8× | 13.8× | 0.7× | 11.4% | — | 3.0% | 10.6% | 9.3% | 0.8× | 615 |
| HST | $17.3B | 22.9× | — | 2.8× | 7.6% | — | 12.5% | 11.7% | 9.8% | — | 656 |
| LAMR | $16.1B | 27.4× | — | 7.1× | 2.7% | 67.0% | 25.9% | 57.3% | 14.0% | — | 655 |
| WPC | $15.8B | — | — | 9.2× | 8.4% | — | 27.2% | 5.7% | 2.8% | — | 834 |
| DOC | $15.1B | 217.9× | — | 5.4× | 4.5% | — | 2.5% | 1.0% | 0.4% | — | 724 |
| SUI | $14.9B | 11.2× | — | 6.5× | 2.0% | — | 61.3% | 20.3% | 20.3% | — | 487 |
| OHI | $14.4B | 25.1× | — | 12.1× | 13.2% | — | 0.1% | 0.0% | 0.0% | — | 718 |
Peers = companies sharing WY's sector (Real Estate) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $606M dividends + $160M buybacks = $766M returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 2%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $464M is below the $522M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~5.4% on $5.0B of debt.
Cash of $464M is below short-term debt of $522M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.91B 100.0% | $7.12B 100.0% | $7.67B 100.0% | $10.18B 100.0% | $10.20B 100.0% | $7.53B 100.0% | $6.55B 100.0% | $7.48B 100.0% | $7.20B 100.0% | $6.37B 100.0% |
| Cost of Revenue | $5.88B 85.2% | $5.81B 81.6% | $5.99B 78.1% | $6.56B 64.5% | $6.10B 59.8% | $5.45B 72.3% | $5.41B 82.6% | $5.59B 74.8% | $5.30B 73.6% | $4.98B 78.2% |
| Cost of Products | — | — | — | — | — | — | — | — | $5.30B 73.6% | $4.98B 78.2% |
| Gross Profit | $1.02B 14.8% | $1.31B 18.4% | $1.68B 21.9% | $3.62B 35.5% | $4.10B 40.2% | $2.08B 27.7% | $1.14B 17.4% | $1.88B 25.2% | $1.90B 26.4% | $1.39B 21.8% |
| Research & Development | $5.0M 0.1% | $7.0M 0.1% | $7.0M 0.1% | $6.0M 0.1% | $5.0M 0.0% | $5.0M 0.1% | $6.0M 0.1% | $8.0M 0.1% | $14.0M 0.2% | $19.0M 0.3% |
| Selling, General & Admin | $453.0M 6.6% | $480.0M 6.7% | $431.0M 5.6% | $398.0M 3.9% | $396.0M 3.9% | $347.0M 4.6% | $348.0M 5.3% | $318.0M 4.3% | $310.0M 4.3% | $338.0M 5.3% |
| Operating Income | $731.0M 10.6% | $685.0M 9.6% | $1.19B 15.5% | $3.08B 30.2% | $3.64B 35.7% | $1.71B 22.7% | $651.0M 9.9% | $1.39B 18.6% | $1.13B 15.7% | $822.0M 12.9% |
| Interest Expense | $273.0M 4.0% | $269.0M 3.8% | $280.0M 3.6% | $270.0M 2.7% | $313.0M 3.1% | $351.0M 4.7% | $378.0M 5.8% | $375.0M 5.0% | $393.0M 5.5% | $431.0M 6.8% |
| Other Income (Expense), net | — | -$15.0M -0.2% | -$30.0M -0.4% | -$24.0M -0.2% | -$25.0M -0.2% | -$35.0M -0.5% | -$28.0M -0.4% | -$52.0M -0.7% | — | — |
| Pretax Income | $260.0M 3.8% | $427.0M 6.0% | $937.0M 12.2% | $2.31B 22.6% | $3.32B 32.5% | $982.0M 13.0% | -$213.0M -3.2% | $807.0M 10.8% | $716.0M 9.9% | $504.0M 7.9% |
| Income Tax Expense | -$64.0M -0.9% | $31.0M 0.4% | $98.0M 1.3% | $425.0M 4.2% | $709.0M 7.0% | $185.0M 2.5% | -$137.0M -2.1% | $59.0M 0.8% | $134.0M 1.9% | $89.0M 1.4% |
| Net Income | $324.0M 4.7% | $396.0M 5.6% | $839.0M 10.9% | $1.88B 18.5% | $2.61B 25.6% | $797.0M 10.6% | -$76.0M -1.2% | $748.0M 10.0% | $582.0M 8.1% | $1.03B 16.1% |
| Per Share | ||||||||||
| EPS (Basic) | $0.45 | $0.54 | $1.15 | $2.53 | $3.48 | $1.07 | $-0.10 | $0.99 | $0.77 | $1.40 |
| EPS (Diluted) | $0.45 | $0.54 | $1.15 | $2.53 | $3.47 | $1.07 | $-0.10 | $0.99 | $0.77 | $1.39 |
| Weighted Avg Shares (Basic) | 723.2M | 728.4M | 731.7M | 741.9M | 749.5M | 746.9M | 745.9M | 754.6M | 753.1M | 718.6M |
| Weighted Avg Shares (Diluted) | 723.6M | 729.0M | 732.2M | 743.0M | 751.0M | 747.9M | 745.9M | 756.8M | 756.7M | 722.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-08-05
No standout strengths flagged.
Where each multiple sits in its own 14-yr range · 75th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 74.8 | 82.6 | 72.3 | 59.8 | 64.5 | 78.1 | 81.6 | 85.2 |
| Gross Profit | 25.2 | 17.4 | 27.7 | 40.2 | 35.5 | 21.9 | 18.4 | 14.8 |
| R&D | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| SG&A | 4.3 | 5.3 | 4.6 | 3.9 | 3.9 | 5.6 | 6.7 | 6.6 |
| Operating Income | 18.6 | 9.9 | 22.7 | 35.7 | 30.2 | 15.5 | 9.6 | 10.6 |
| Income Tax | 0.8 | -2.1 | 2.5 | 7.0 | 4.2 | 1.3 | 0.4 | -0.9 |
| Net Income | 10.0 | -1.2 | 10.6 | 25.6 | 18.5 | 10.9 | 5.6 | 4.7 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on WY: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.